课题基金 / 基金详情

NMD4C: An integrated research network for patients, scientists, and clinicians to improve outcomes and access to therapies for patients with neuromuscular disorders in Canada.

NMD4C: An integrated research network for patients, scientists, and clinicians to improve outcomes and access to therapies for patients with neuromuscular disorders in Canada.
NMD4C：一个面向患者、科学家和临床医生的综合研究网络，旨在改善加拿大神经肌肉疾病患者的治疗结果和获得治疗的机会。
批准号：
417346
负责人：
Lochmüller Hanns
金额：
$43.71万
依托单位：
Children's Hospital of Eastern Ontario Research Institute Inc
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2019
资助国家：
加拿大
项目状态：
已结题
起止时间：
2019-08-01 至 2022-08-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=417346&lang=en
关键词：
Genomics Knowledge Translation Networks Neuromuscular Disease Patient Engagement Translational Research

项目摘要

项目成果

Lochmüller Hanns的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Muscular dystrophies and other neuromuscular disorders (NMDs) are rare genetic conditions that affect the skeletal muscles, nerves controlling the muscles, or junctions between muscle and nerve. More than 64,000 Canadians are affected by NMDs, 40% of whom
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NMD4C: the neuromuscular network for Canada
Novel therapeutic approaches to target GNE Myopathy
Inherited disorders of neuromuscular transmission in humans: understanding and manipulating molecular and cellular structure-function relationships at the motoneuron to muscle interface, the neuromuscular synapse, through a translational medicine approach
Canada Research Chair Tier 1
  • 批准号：
    392579
  • 项目类别：
  • 资助金额：
    $101.99万
  • 财政年份：
    2018
  • 负责人：
    Lochmüller Hanns
  • 依托单位：
    University of Ottawa
海外基金